Evidence that the receptor for soluble CD14:LPS complexes may not be the putative signal-transducing molecule associated with membrane-bound CD14

Scandinavian Journal of Immunology

Volumn 46, Issue 3, 1997, Pages 242-245

  Haziot, A ^a   Katz, I ^a   Rong, G W ^a   Lin, X Y ^a   Silver, J ^a   Goyert, S M ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN;

ARTICLE; COMPLEX FORMATION; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030880553     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-124.x     Document Type: Article

References (22)

1. Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, Le Beau MM. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988; 239:497-500.
2. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988;141: 547-52.
3. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-3.
4. Haziot A, Tsuberi B, Goyert SM. Neutrophil CD14: biochemical properties and role in the secretion of TNFα in response to LPS. J Immunol 1993;150:5556-65.
5. Haziot A, Ferrero E, Koentgen F et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996;4:407-14.
6. Maliszewski CR, Ball ED, Graziano RF, Fanger MW. Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-2. Immunol 1985;135:1929-36.
7. Bazil V, Horejsi V, Baudys M et al. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol 1986;16:1583-9.
8. Patrick D, Betts J, Fray EA, Prameya R, Dorovini-Zis K, Finlay BB. Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cytotoxic pathway. J Infect Dis 1992;165:865-72.
9. Haziot A, Rong GW, Silver J, Goyert SM. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol 1993;151:1500-7.
10. Sundan A, Ryan L, Brinch L, Espevik T, Waage A. The involvement of CD14 in stimulation of TNF production from peritoneal mononuclear cells isolated from PNH patients. Scand J Immunol 1995; 41:603-8.
11. Golenbock DT, Bach RR, Lichenstein H, Juan TS, Tadavarthy A, Moldow CF. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. J Lab Clin Med 1995;125:662-71.
12. Schutt C, Schilling T, Grunwald U et al. Human monocytes lacking the membrane-bound form of the bacterial lipopolysaccharide (LPS) receptor CD14 can mount an LPS-induced oxidative burst response mediated by a soluble form of CD14. Res Immunol 1995;146:339-50.
13. Lee J-D, Kravchenko V, Kirkland TN et al. GPI-anchored or integral membrane forms of CD14 mediate identical responses to endotoxin. Proc Natl Acad Sci USA 1993;90:9930-4.
14. Kitchens RL, Munford RS. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biol Chem 1995;270:9904-10.
15. DeLude RL, Savedra R, Zhao H et al. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Natl Acad Sci USA 1995;92:9288-92.
16. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
17. Dimitriu-Bona A, Burmester GR, Waters SJ, Winchester RJ. Human mononuclear phagocyte differentiation antigen. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies. J Immunol 1983;130: 145-52.
18. Schutt C, Ringel B, Nausch M et al. Human monocyte activation induced by an anti-CD14 monoclonal antibody. Immunol Lett 1988;19:321-7.
19. Todd RF III. Myeloid antigens: section report. In: Schlossman SFEA, ed. Leucocyte Typing V. Oxford University Press, Oxford, 1995;739-70.
20. Haziot A, Rong GW, Bazil V, Silver J, Goyert SM. Recombinant soluble CD14 inhibits LPS-induced Tumor Necrosis Factor-α production by cells in whole blood. J Immunol 1994;152:5868-76.
21. Juan TSC, Hailman E, Kelley MJ, Wright SD, Lichenstein HS. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J Biol Chem 1995;270:17237-42.
22. Gegner J, Ulevitch R, Tobias P. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD1. J Biol Chem 1995;270:5320-5.